| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1134 | 14 | 730 | 95 | 1157 | 179 | 1090 |
| ERLYTX | 74 | 2 | 104 | 7 | 85 | 9 | 55 |
| GI | 169 | 4 | 209 | 22 | 268 | 35 | 213 |
| GU | 411 | 10 | 522 | 58 | 706 | 99 | 603 |
| LEUK | 168 | 6 | 313 | 20 | 244 | 36 | 219 |
| LUNG | 211 | 1 | 52 | 19 | 231 | 32 | 195 |
| LYMPH | 425 | 5 | 261 | 36 | 438 | 65 | 396 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 112 | 0 | 0 | 10 | 122 | 22 | 134 |
| MULT | 47 | 1 | 52 | 2 | 24 | 4 | 24 |
| OTHER | 44 | 0 | 0 | 2 | 24 | 2 | 12 |
| Total | 2803 | 43 | 2243 | 272 | 3311 | 484 | 2947 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 214 | 2 | 104 | 17 | 207 | 35 | 213 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 6 | 0 | 0 | 1 | 12 | 4 | 24 |
| LEUK | 620 | 11 | 574 | 57 | 694 | 112 | 682 |
| LUNG | 370 | 3 | 157 | 39 | 475 | 67 | 408 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 17 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 55 | 1 | 52 | 4 | 49 | 4 | 24 |
| PREV | 225 | 2 | 104 | 19 | 231 | 30 | 183 |
| SXQOL | 649 | 11 | 574 | 49 | 597 | 103 | 627 |
| Total | 2160 | 30 | 1565 | 189 | 2301 | 360 | 2191 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1134 | 14 | 730 | 95 | 1157 | 179 | 1090 |
| CCD | 214 | 2 | 104 | 17 | 207 | 35 | 213 |
| ERLYTX | 76 | 2 | 104 | 7 | 85 | 9 | 55 |
| GI | 170 | 4 | 209 | 22 | 268 | 35 | 213 |
| GU | 417 | 10 | 522 | 59 | 718 | 103 | 627 |
| LEUK | 788 | 17 | 887 | 77 | 937 | 148 | 901 |
| LUNG | 581 | 4 | 209 | 58 | 706 | 99 | 603 |
| LYMPH | 426 | 5 | 261 | 37 | 450 | 66 | 402 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 112 | 0 | 0 | 10 | 122 | 22 | 134 |
| MULT | 47 | 1 | 52 | 2 | 24 | 4 | 24 |
| OTHER | 61 | 0 | 0 | 4 | 49 | 6 | 37 |
| PEOLC | 55 | 1 | 52 | 4 | 49 | 4 | 24 |
| PREV | 225 | 2 | 104 | 19 | 231 | 30 | 183 |
| SXQOL | 649 | 11 | 574 | 49 | 597 | 103 | 627 |
| Total | 4963 | 73 | 3808 | 461 | 5612 | 844 | 5139 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 695 | 7 | 365 | 66 | 804 | 108 | 657 |
| ERLYTX | 55 | 2 | 104 | 7 | 85 | 9 | 55 |
| GI | 133 | 4 | 209 | 18 | 219 | 29 | 177 |
| GU | 302 | 6 | 313 | 42 | 511 | 67 | 408 |
| LEUK | 103 | 3 | 157 | 9 | 110 | 17 | 103 |
| LUNG | 136 | 1 | 52 | 14 | 170 | 23 | 140 |
| LYMPH | 278 | 2 | 104 | 22 | 268 | 41 | 250 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 64 | 0 | 0 | 6 | 73 | 12 | 73 |
| MULT | 19 | 0 | 0 | 1 | 12 | 2 | 12 |
| OTHER | 44 | 0 | 0 | 2 | 24 | 2 | 12 |
| Total | 1837 | 25 | 1304 | 188 | 2288 | 311 | 1893 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 156 | 1 | 52 | 9 | 110 | 24 | 146 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 6 | 0 | 0 | 1 | 12 | 4 | 24 |
| LEUK | 252 | 6 | 313 | 23 | 280 | 41 | 250 |
| LUNG | 227 | 2 | 104 | 28 | 341 | 47 | 286 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 17 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 47 | 1 | 52 | 4 | 49 | 4 | 24 |
| PREV | 225 | 2 | 104 | 19 | 231 | 30 | 183 |
| SXQOL | 474 | 7 | 365 | 35 | 426 | 71 | 432 |
| Total | 1408 | 19 | 990 | 122 | 1485 | 226 | 1375 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 890 | 11 | 574 | 86 | 1047 | 149 | 907 |
| CCD | 164 | 1 | 52 | 9 | 110 | 20 | 122 |
| ERLYTX | 57 | 2 | 104 | 7 | 85 | 9 | 55 |
| GI | 144 | 3 | 157 | 17 | 207 | 31 | 189 |
| GU | 338 | 5 | 261 | 40 | 487 | 69 | 420 |
| LEUK | 358 | 9 | 470 | 32 | 390 | 58 | 353 |
| LUNG | 396 | 3 | 157 | 46 | 560 | 74 | 450 |
| LYMPH | 279 | 2 | 104 | 23 | 280 | 42 | 256 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 64 | 0 | 0 | 6 | 73 | 12 | 73 |
| MULT | 41 | 0 | 0 | 3 | 37 | 6 | 37 |
| OTHER | 115 | 0 | 0 | 4 | 49 | 6 | 37 |
| PEOLC | 50 | 1 | 52 | 3 | 37 | 6 | 37 |
| PREV | 225 | 2 | 104 | 19 | 231 | 30 | 183 |
| SXQOL | 474 | 7 | 365 | 35 | 426 | 71 | 432 |
| Total | 3603 | 46 | 2400 | 331 | 4031 | 584 | 3557 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 988 | 12 | 626 | 88 | 1071 | 169 | 1029 |
| ERLYTX | 70 | 2 | 104 | 6 | 73 | 8 | 49 |
| GI | 99 | 3 | 157 | 13 | 158 | 22 | 134 |
| GU | 298 | 8 | 417 | 48 | 584 | 76 | 463 |
| LEUK | 137 | 5 | 261 | 17 | 207 | 32 | 195 |
| LUNG | 185 | 1 | 52 | 16 | 195 | 28 | 170 |
| LYMPH | 355 | 5 | 261 | 36 | 438 | 61 | 371 |
| MMYEL | 99 | 0 | 0 | 9 | 110 | 21 | 128 |
| MULT | 47 | 1 | 52 | 2 | 24 | 4 | 24 |
| Total | 2278 | 37 | 1930 | 235 | 2860 | 421 | 2563 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1902 | 27 | 1409 | 190 | 2313 | 315 | 1918 |
| AFFIL | 123 | 1 | 52 | 7 | 85 | 9 | 55 |
| CCOP/NCORP | 1220 | 16 | 835 | 113 | 1376 | 213 | 1297 |
| Non-SWOG | 1715 | 26 | 1357 | 148 | 1802 | 304 | 1851 |
| Total | 4960 | 70 | 3653 | 458 | 5576 | 841 | 5121 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LUNG | S1900J | MET Amplification: Amivantamab Hyaluronidase | 1 | N | 15-OCT-26 |
| OTHER | NRGHN009 | HN, RT + HD Cisp vs RT + LD Cisp for SCCHN | 1 | E | 02-OCT-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 11 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 8 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 4 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 3 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 3 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 2 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | 3 |
| GU | S2427 | Blad, MIBC, RT + Pembrolizumab | 1 | 3 |